RL
RLMD
Relmada Therapeutics $4.52 1M -4.2% 3M -30.7% YTD +3.4% as of 2026-09-11↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
+0.3%
Next 1 month
-0.3%
Seasonality
Mildly negative window
Next 30 days (to Oct 14): -5.4% median,
45% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 85
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.00%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.77 -0.3% · Seasonal tilt (11y) -0.1%
$5M/day volume
104% volatility
+181% 1-year
52-week range · 47% of the way up · -44% from the high
$1.44$8.00
Congressional trades in RLMD Full tracker →
1 member · 1 buys / 1 sells · $2K–$30K disclosed · latest filing Jan 20, 2023.
| SELL | $1K–$15K | |
| BUY | $1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.